H.R. 4348
To reauthorize the Kay Hagan Tick Act, and for other purposes.
Sponsor: Christopher H. Smith
36 cosponsors
- Chellie Pingree
- Mike Thompson
- Suhas Subramanyam
- Julie Johnson
- Scott H. Peters
- Emilia Strong Sykes
- Jefferson Van Drew
- Mikie Sherrill
- James A. Himes
- Christopher R. Deluzio
- Deborah K. Ross
- Jamie Raskin
- John W. Mannion
- Lloyd Doggett
- Paul Tonko
- Thomas H. Kean, Jr.
- Mike Levin
- Sarah McBride
- Zoe Lofgren
- Seth Magaziner
- Robert P. Bresnahan, Jr.
- Brian K. Fitzpatrick
- Josh Riley
- Cliff Bentz
- John H. Rutherford
- Eugene Simon Vindman
- James C. Moylan
- Andrew R. Garbarino
- Timothy M. Kennedy
- Donald G. Davis
- Josh Gottheimer
- Sharice Davids
- William R. Keating
- Gwen Moore
- Nikki Budzinski
- Nellie Pou
Official summary
Written by the Congressional Research Service.
This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.
Text of the bill
(a) National strategy and regional centers of excellence in vector-Borne disease. Section 317U of the Public Health Service Act (42 U.S.C. 247b–23) is amended—
(1) in subsection (b), in the matter preceding paragraph (1), by striking the Tick-Borne Disease Working Group established under section 2062 of the 21st Century Cures Act (42 U.S.C. 284s) and other individuals, as appropriate and inserting appropriate individuals;
(2) in subsection (c)(4), by inserting , including by increasing capacity to identify, report, prevent, and respond to such diseases before the period at the end; and
(3) in subsection (f), by striking 2021 through 2025 and inserting 2026 through 2030.
(b) Enhanced support To assist health departments in addressing vector-Borne diseases. Section 2822(c) of the Public Health Service Act (42 U.S.C. 300hh–32(c)) is amended by striking 2021 through 2025 and inserting 2026 through 2030.